Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

UiPath Exceeds Expectations with Record Sales and Profitable Quarter

Elaine Mendonca by Elaine Mendonca
March 13, 2024
in Breaking News
0
ES stock news
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

UiPath has exceeded expectations in Q4 of 2024, achieving record sales and marking its first profitable quarter since going public.

—

Earnings per share were reported at 22 cents, beating analyst estimates by 37.5%. Sales for the quarter reached $405.253 million, a significant increase compared to the same period last year.

—

The company also achieved GAAP profitability and saw strong cash flow from operations, with non-GAAP adjusted free cash flow hitting $146 million.

—

Looking forward, UiPath anticipates first-quarter revenue to fall between $330 million and $335 million.

—

These results demonstrate UiPath’s impressive growth, operational efficiency, and competitive edge in the software industry.

PATH Stock Performance on March 13, 2024: Fluctuations and Recovery in After-Hours Trading

On March 13, 2024, PATH stock experienced fluctuations in its performance. According to data from CNN Money, PATH was trading near the top of its 52-week range and above its 200-day simple moving average, indicating good performance in the medium to long term.

However, on that day, the price of PATH shares decreased by $0.21, representing a 0.85% drop. The stock closed at $24.43, lower than the previous closing price. Despite this decrease, there was a slight recovery in after-hours trading, with the stock rising by $0.28.

Overall, the performance of PATH stock on March 13, 2024, was mixed. Investors should monitor further developments in the stock’s performance to make informed decisions about their investments.

It is important to conduct thorough research and analysis before making any investment decisions, as stock market performance can be influenced by various factors such as market conditions, company news, and economic indicators.

PATH Stock Shows Promising Performances with Impressive Financial Results in 2024

On March 13, 2024, PATH stock showed promising performances as the company reported impressive financial results. According to data from CNN Money, PATH’s total revenue for the past year stood at $1.06 billion, marking an 18.64% increase compared to the previous year. In the third quarter alone, the company generated $325.92 million in total revenue, reflecting a 13.44% increase since the previous quarter.

Despite reporting a net income of -$328.35 million for the past year, PATH managed to improve its financial position significantly, with a 37.53% increase in net income compared to the previous year. In the third quarter, the company reported a net income of -$31.54 million, representing a 47.75% increase since the previous quarter.

Furthermore, PATH’s earnings per share (EPS) also showed positive growth trends. The company reported an EPS of -$0.60 for the past year, marking a 38.3% increase compared to the previous year. In the third quarter, PATH’s EPS was -$0.06, reflecting a 48.13% increase since the previous quarter.

Overall, PATH’s stock performances on March 13, 2024, demonstrated the company’s ability to drive revenue growth, improve its financial position, and increase shareholder value. Investors may view these results as a positive indicator of the company’s future prospects and potential for long-term growth.

Tags: PATH
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Technology Data analytics stock Trading (1)

SentinelOne Stock Plummets After Disappointing Fiscal 2025 Guidance

DrugRetailers Stock Exchange

GrowGeneration Reports Quarterly Losses but Exceeds Sales Estimates

Food Retailers Stock Bull Market

The Power of Compounded Returns A Case Study on Lowes Companies

Recommended

Jakks Pacific Reports Disappointing Q4 2023 Earnings

2 years ago
Ecommerce Stock Exchange

Notable Options Market Activity for Shopify

2 years ago
Fannie Mae Stock

Fannie Mae’s Public Offering Plans Derailed by Prominent Investor

3 months ago
Ocugen Stock

Ocugen Shares Face Critical Test Amid Steep Decline

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Trending

Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

by Rodolfo Hanigan
February 7, 2026
0

Investors in Viking Therapeutics are currently focused on a specific calendar event rather than breaking news. The...

Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment
  • Diginex Enters Critical Implementation Phase Following Strategic Moves
  • Deluxe Stock Gains Momentum on Successful Fintech Transition

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com